IQtech Closes First Investment Round Backed by Selexi and Yuniro

Why It Matters

The funding propels iQtech into a growth phase, positioning XR‑based medical training as a scalable solution for a region hungry for advanced health‑education tools. It signals increasing investor confidence in AI‑driven simulation technologies within emerging markets.

Key Takeaways

• iQtech closed first funding round
• Backers: Selexi and Yuniro
• Funding targets XR medical platform EsculapioVR
• Expansion planned across Qatar and MENA
• Platform serves healthcare, civil, military training

Pulse Analysis

Extended reality is reshaping how clinicians acquire hands‑on experience, and Qatar’s strategic push for knowledge‑based industries makes it a fertile ground for innovators. iQtech, founded in 2025 within the Qatar Science & Technology Park, leverages this momentum by marrying high‑fidelity VR environments with AI analytics. The startup’s timing aligns with regional health ministries seeking cost‑effective, repeatable training that reduces reliance on scarce cadaver labs and live patients, while also meeting accreditation standards.

EsculapioVR, iQtech’s flagship offering, differentiates itself through real‑time performance scoring powered by machine‑learning algorithms. Trainees navigate realistic surgical scenarios, and the system automatically benchmarks their decisions against clinical best practices. Beyond hospitals, the platform’s modular architecture supports civil emergency drills and military medical readiness, expanding its addressable market. The infusion of capital from Selexi, a leader in assessment technology, and Yuniro, a deep‑tech collaborator, provides both financial muscle and technical expertise to fast‑track product refinement and cloud infrastructure scaling.

For the MENA region, iQtech’s expansion promises to democratize advanced medical training, reducing skill gaps and enhancing patient safety. As governments invest in digital health initiatives, an AI‑enhanced XR solution can become a cornerstone of national curricula, attracting further private and public partnerships. If iQtech successfully deploys across multiple countries, it could set a benchmark for homegrown healthtech innovation, encouraging similar ventures to pursue immersive, data‑driven education models.

Deal Summary

Qatar-based healthtech startup iQtech announced the close of its first investment round, raising an undisclosed amount from European assessment technology firm Selexi and deep‑tech partner Yuniro. The funding will accelerate development of its AI‑powered XR medical simulation platform, EsculapioVR, and support expansion across Qatar and the MENA region.